<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="104013">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01669161</url>
  </required_header>
  <id_info>
    <org_study_id>Mt-St-01</org_study_id>
    <nct_id>NCT01669161</nct_id>
  </id_info>
  <brief_title>Paired Vagus Nerve Stimulation (VNS) With Rehabilitation for Upper Limb Function Improvement After Stroke</brief_title>
  <official_title>A Proof-of-Concept Pilot Study Assessing Vagus Nerve Stimulation (VNS) Paired With Rehabilitation for Improved Upper Limb Function After Stroke (MicroTransponder's Vivistim System)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>MicroTransponder Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>MicroTransponder Inc.</source>
  <oversight_info>
    <authority>United Kingdom: Medicines and Healthcare Products Regulatory Agency</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Patients (UK only) at least 6 months post stroke, with upper limb deficits, may enroll.
      Patients will be randomized to one of two groups - a group implanted with a device that
      allows pairing VNS with rehabilitation and a group that only receives rehabilitation (no
      implant).  Patients have two baseline evaluations, one evaluation after implant but before
      initiation of treatment, and then six weeks of rehabilitation or rehabilitation + VNS,
      followed by post acute therapy evaluations at 1, 7, and 30 days after the 6-weeks of
      treatment.  The intent is to assess safety and provide preliminary effectiveness information
      for VNS for upper limb functional improvement after stroke.  Implanted patients may receive
      longer-term treatment and follow-up after the acute study.
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>February 2013</start_date>
  <completion_date type="Anticipated">December 2014</completion_date>
  <primary_completion_date type="Anticipated">July 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Safety</measure>
    <time_frame>6-weeks</time_frame>
    <safety_issue>No</safety_issue>
    <description>Assessment of adverse events and serious adverse events.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Stroke</condition>
  <arm_group>
    <arm_group_label>VNS</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>VNS (vagus nerve stimulation) paired with rehabilitation as provided by the Vivistim System.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Rehab Only</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Rehabilitation only (no implant, no VNS)</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Vivistim System</intervention_name>
    <description>The Vivistim System provides vagus nerve stimulation (VNS) with rehabilitation movements.</description>
    <arm_group_label>VNS</arm_group_label>
    <other_name>VNS, vagus nerve stimulation, paired VNS</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Rehab Only</intervention_name>
    <description>Rehabilitation without device implant and VNS</description>
    <arm_group_label>Rehab Only</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Major Inclusion Criteria:

          1. History of unilateral supratentorial ischemic stroke that occurred at least 6 months
             prior

          2. Age &gt; 18 years and &lt; 80 years

          3. Right or left sided weakness of upper extremity

        Major Exclusion Criteria:

          1. Hemorrhagic stroke

          2. Any deficits in language or attention that interferes with reasonable study
             participation

          3. Presence of significant apraxia

          4. Profound Sensory loss

          5. Active major neurological or psychiatric diagnosis that would likely interfere with
             study protocol including alcohol or drug abuse
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jesse Dawson, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>U. Glasgow</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>U. Glasgow / Western Infirmary</name>
      <address>
        <city>Glasgow, Scotland</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>April 2014</verification_date>
  <lastchanged_date>April 23, 2014</lastchanged_date>
  <firstreceived_date>August 15, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Upper</keyword>
  <keyword>Limb</keyword>
  <keyword>Deficits</keyword>
  <keyword>Rehabilitation</keyword>
  <keyword>VNS</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Stroke</mesh_term>
    <mesh_term>Cerebral Infarction</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
